Advanced glycation end-products (AGEs) were produced in vitro using a method described previously [17]. In brief, Bovine Serum Albumin (BSA, 20 mg/mL) in phosphate buffered-saline solution (PBS, pH 7.4) containing 0.02% sodium azide was incubated with glucose (500 mM) at 37 °C for 0, 7, 14, 21, and 28 days in the absence (control) and presence of each of the extracts (100, 200, and 400 μg/mL) or AG (200 μg/mL). Each solution was kept in the dark in a capped vial, and incubation was allowed to proceed in triplicated vials. For time course experiments involving fluorescent AGE formation, we measured the fluorescence (370-nm excitation wavelength and 440-nm emission wavelength) using an F-2500 Spectrofluorometer (Hitachi, Tokyo, Japan). The percentage inhibition was calculated using the following formula:
The effective concentration for 50% inhibition (IC50) was obtained by interpolation of the linear regression analysis. All determinations were performed in triplicate, and the results were averaged and compared using the Duncan’s multiple range test (p < 0.05).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.